Glend Llandtada - Philippines

“The FDA’s fast-tracking of X-ray facility licensing is an important step to combat COVID-19.”

Glend Llandtada, Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines FDA Alters Requirements for Radiation Licensing During COVID-19

Published on: December 17th, 2020

Interim Guidelines for the Conduct of Licensing Inspection for Radiation Facilities

The FDA has issued FDA Circular No. 2020-035, which pertains to Interim Guidelines for the Conduct of Licensing Inspection for Radiation Facilities. Under this Circular, any pending applications will be nullified, requiring new applications to be submitted. Below are the interim guidelines for the conduct of pre-licensing inspections of Health Physics teams of the CDRRHR of the FDA.

Note: This Circular shall take effect November 19th 2020

The following facilities applying use of radiation devices during COVID-19 measures:

  • Diagnostic X-ray Facilities
  • Therapeutic X-ray Facilities utilizing Medical Linear Accelerator
  • Dental X-ray Facilities
  • Industrial and Anti-Crime X-ray Facilities
  • Education and Research X-ray Facilities
  • Veterinary X-ray Facilities
  • Transportable X-ray Facilities
  • Magnetic Resonance Imaging Facilities

However, the FDA will resume pre-licensing inspections for Medical Linear Accelerators. This can be done either online or by virtual inspection. For other types of radiation facilities, authorization will be done using an interim radiation facility authorization process and will be verified with a post-licensing inspection when quarantine measures end.

Grow with US

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests.

Blog Posts

Japan's Innovative Medical Device Regulatory Pathway is called Sakigake

Innovative Medical Device Registration in Japan

In 2019, Japan's Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.
Read more
PMDA Representative consulting with medical device manufacturers in Japan

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).
Read more
Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more